Consistently, these data indicated that compound DBH2 could promote the intracellular level of substrates of caspase-3 including PARP1 and ROCK1, thus resulting in the apoptosis of CML cells. The gene discussed is PARP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.